下调和上调
脂肪性肝炎
癌症研究
肝星状细胞
纤维化
串扰
炎症
细胞生物学
GPX4
肝纤维化
脂质过氧化
化学
脂肪肝
信号转导
调节器
脂质代谢
脂肪变性
生物
Wnt信号通路
肝损伤
平衡
细胞
过氧化物酶体增殖物激活受体
细胞保护
肝细胞学
肿瘤坏死因子α
肝病
受体
转录因子
免疫学
肝癌
代谢途径
基因表达调控
作者
Y H Kim,Jina Kim,Da Young An,Mihyang Park,Gui-Hwa Jeong,Jonghwa Jin,Mi Kyung Kim,Jungwook Chin,Yeon‐Kyung Choi,Keun‐Gyu Park
标识
DOI:10.1038/s12276-026-01740-0
摘要
Recently, ferroptosis has emerged as a pathogenic mechanism that drives metabolic dysfunction-associated steatohepatitis (MASH); however, the upstream triggers and their relevance to fibrosis remain poorly understood. Here we identified dietary cholesterol-induced ferroptosis and the downregulation of peroxisome proliferator-activated receptor delta (PPARδ) as central drivers of MASH pathogenesis. To investigate this, human liver samples and cholesterol-enriched dietary murine models of MASH were examined in parallel with mechanistic studies in hepatocytes and hepatic stellate cells (HSCs). Cholesterol-induced MASH was associated with pronounced hepatic lipid peroxidation and the selective downregulation of PPARδ. The loss of PPARδ disrupted redox homeostasis and sensitized hepatocytes to ferroptosis, whereas exosomal double-stranded DNA released from ferroptotic hepatocytes activated STING-TBK1-IRF3 and induced expression of profibrotic genes in HSCs. These effects were reversed by either overexpression of hepatocyte-specific PPARδ or pharmacologic treatment with DN203316, a novel and highly selective PPARδ agonist. In vivo, DN203316 mitigated ferroptosis, inflammation and fibrosis without inducing metabolic derangement. These findings were substantiated by clinical data demonstrating a marked increase in lipid peroxidation and STING-driven HSC activation in liver tissues from patients with MASH. In conclusion, PPARδ is a key regulator of cholesterol-induced ferroptosis and exosome-mediated fibrogenic signaling in MASH. DN203316 offers a promising therapeutic strategy to suppress ferroptosis, disrupt hepatocyte-HSC crosstalk and attenuate disease progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI